ACIP Influenza Prevention and Control Recommendations, 1999-2000 Update

An updated 1998 report from the Advisory Committee on Immunization Practices provides recommendations on influenza vaccine and antiviral agents. The report includes new information on the 1999-2000 trivalent vaccine strains, live-attenuated influenza vaccines, neuraminidase-inhibitor drugs, and rapid diagnostic tests. It also discusses the expanded use of influenza vaccine and the epidemiology of influenza among travelers.

Use Cases

• Analyzing changes in vaccine recommendations based on the updated 1998 guidelines mentioned in the description
• Studying the epidemiology of influenza among travelers based on the new background information provided
• Comparing vaccine strain information for the 1999-2000 trivalent vaccine as detailed in the report
• Reviewing the discussion on the potential expanded use of influenza vaccine for policy planning

Strengths

• Report updates a prior 1998 publication (MMWR 1998;47[No. RR-6]:1-26), providing a clear lineage.
• Includes new information on multiple specific topics: vaccine strains, LAIVs, antiviral drugs, and diagnostic tests.
• Contains referenced citations, suggesting a foundation in prior literature.

Limitations

• Row count is unknown, which may limit suitability assessment.
• Column-level documentation is absent; field semantics must be inferred after download.
• Last update date is unknown; freshness unverified.

Provenance

Source

Advisory Committee on Immunization Practices (ACIP), CDC

Collection Method

Expert committee recommendations and report compilation.

Time Range

Report updates 1998 recommendations and includes information for the 1999-2000 influenza season.